Fundz

Aslan Pharmaceuticals Ltd reported raising $5 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEMar 28, 2024

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Mar 14, 2024)

Round Type

Venture

SingaporeManufacturingBiotechnology

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as ASLAN Pharmaceuticals Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Yoneda Labs raised $4M (Seed) on April 26, 2024.
  • Vitro3D raised $3.9M (Seed) on April 26, 2024.
  • R3 Vascular raised $72M on April 26, 2024.
  • Nami Surgical raised $123K (Pre-Seed) on April 22, 2024.
  • Harvard Apparatus Regenerative Technology raised $1.5M on April 15, 2024.
  • OsseoLabs raised $2M (Series A) on April 15, 2024.

Who to call at ASLAN Pharmaceuticals Ltd, and when

A new round usually means ASLAN Pharmaceuticals Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ASLAN Pharmaceuticals Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ASLAN Pharmaceuticals Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ASLAN Pharmaceuticals Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ASLAN Pharmaceuticals Ltd

Location

3 Temasek Avenue

Singapore, Southeast Asia, Singapore

About

ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is developing eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor in moderate-to-severe atopic dermatitis, and farudodstat, a potent oral inhibitor of the enzyme DHODH, as a potential first-in-class treatment for alopecia areata. ASLAN has teams in San Mateo, California, and in Singapore.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ASLAN Pharmaceuticals Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ASLAN Pharmaceuticals Ltd's next move

See what Strategic adds

ASLAN Pharmaceuticals Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.